Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Fractures, Bone (Phase 3)
Fractures, Stress (Phase 3)
Gastrointestinal Neoplasms (Phase 2)
General Surgery (Phase 3)
Genital Neoplasms, Female (Phase 1)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Hamartoma (Phase 3)
Hemangiosarcoma (Phase 2)
Kidney Diseases (Phase 1)
Kidney Failure, Chronic (Phase 1)
Leukemia, Monocytic, Acute (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Myelomonocytic, Acute (Phase 1)
Lung Neoplasms (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 1)
Oligodendroglioma (Phase 2)
Ovarian Neoplasms (Phase 3)
Pain (Phase 3)
Prostatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Sarcoma (Phase 2)
Sprains and Strains (Phase 3)
Tendinopathy (Phase 3)
Uterine Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue